Literature DB >> 7516322

Contribution of potassium channels to active hyperemia of the canine diaphragm.

G Vanelli1, H Y Chang, A G Gatensby, S N Hussain.   

Abstract

Glibenclamide, iberiotoxin, and apamin (blockers of ATP-sensitive, large-conductance, and small-conductance Ca(2+)-activated K+ channels, respectively) were infused into the diaphragmatic vasculature of anesthetized indomethacin-treated dogs to assess the contribution of K+ channels to active hyperemia. Diaphragmatic blood flow (Qphr) and O2 uptake (VO2di) were measured at rest and during 2 min of continuous left phrenic nerve stimulation at 0.5, 1, 2, and 4 Hz. These measurements were repeated before (control) and after the infusion of a selective K+ channel blocker in three groups of animals. Glibenclamide at 10(-5) M significantly attenuated Qphr at rest and in response to all stimulation frequencies. Whereas resting VO2di remained unchanged, glibenclamide infusion significantly reduced VO2di in response to all stimulation frequencies. The slope of the linear relationship between Qphr and VO2di, however, was not affected by glibenclamide. By comparison, infusion of iberiotoxin (10(-7) M) in a second group reduced Qphr at rest and in response to 0.5- and 1-Hz stimulation, whereas Qphr measured in response to 2- and 4-Hz stimulation remained similar to control values. Apamin (10(-6) M) infusion in a third group reduced only resting Qphr with no effect on active hyperemia during phrenic nerve stimulation. Neither iberiotoxin nor apamin influenced resting or stimulated VO2di. In all groups diaphragmatic tension measured after the infusion of K+ channel blockers remained similar to control values. These results indicate that K+ channels, especially those sensitive to glibenclamide, modulate the increase in Qphr and VO2di in response to moderate augmentation of metabolic demands.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516322     DOI: 10.1152/jappl.1994.76.3.1098

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 2.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

3.  Vascular KATP channels mitigate severe muscle O2 delivery-utilization mismatch during contractions in chronic heart failure rats.

Authors:  Clark T Holdsworth; Scott K Ferguson; Trenton D Colburn; Alexander J Fees; Jesse C Craig; Daniel M Hirai; David C Poole; Timothy I Musch
Journal:  Respir Physiol Neurobiol       Date:  2017-01-22       Impact factor: 1.931

Review 4.  Ion channels and vascular tone.

Authors:  W F Jackson
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

Review 5.  Potassium channels in the peripheral microcirculation.

Authors:  William F Jackson
Journal:  Microcirculation       Date:  2005 Jan-Feb       Impact factor: 2.628

6.  ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.

Authors:  G D Thomas; J Hansen; R G Victor
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

7.  Metabolic hyperemia requires ATP-sensitive K+ channels and H2O2 but not adenosine in isolated mouse hearts.

Authors:  Xueping Zhou; Bunyen Teng; Stephen Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-08       Impact factor: 4.733

8.  Cardiovascular responses to glibenclamide during endotoxaemia in the pig.

Authors:  G Vanelli; S N Hussain; M Dimori; G Aguggini
Journal:  Vet Res Commun       Date:  1997-04       Impact factor: 2.459

9.  Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow.

Authors:  D J Duncker; N S van Zon; Y Ishibashi; R J Bache
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.